January 9, 2026 - To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical trial for people with gastrointestinal cancers, such as cancers of the stomach, colon, and esophagus. The PAGODA trial (Alliance A232402CD) will test a proactive approach to chemotherapy dose adjustments, aiming to minimize treatment interruptions and help patients c
January 8, 2026
The 2026 ASCO Gastrointestinal Cancers Symposium will take place January 8-10, 2026, at the Moscone West Convention Center in San Francisco, CA. It brings together researchers, clinicians, industry leaders, and multidisciplinary teams to share cutting-edge research findings, clinical trial results, translational science, and advances in GI cancer care. The pr
January 5, 2026 - The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance A032304) to explore whether doctors can optimize the timing of targeted radiation therapy to minimize side effects while preserving efficacy in men with advanced prostate cancer.
“Our goal in this trial is to strategically improve both survival and quality
